from Reuters: Business News https://ift.tt/2tU1KjE
Wednesday, March 6, 2019
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on use of the drug, which it warned could be misused and abused.
from Reuters: Business News https://ift.tt/2tU1KjE
from Reuters: Business News https://ift.tt/2tU1KjE
Related Posts:
As Britain decides, Europe grapples with Huawei conundrum- Whirlpool forecasts 2020 largely above estimates as profit beats
- Asian shares, bond yields fall as deadly coronavirus spreads
- Mexico's America Movil fined by regulator; calls it 'illegal and disproportionate'
- Sainsbury's targets 2040 for net zero emissions, criticizes UK goal
0 comments:
Post a Comment